D Du, C Liu, M Qin, X Zhang, T Xi, S Yuan… - … Pharmaceutica Sinica B, 2022 - Elsevier
… Metabolic dysregulation is emphasized in the pathogenesis of hepatocellular carcinoma (HCC),
thus agents or chemicals are developed as potentials to treat HCC by targeting …